Chlamydia pneumoniae infection of the central nervous system in multiple sclerosis

Annals of Neurology

Volumn 46, Issue 1, 1999, Pages 6-14

  Sriram, Subramaniam ^a,b   Stratton, Charles W ^a   Yao, Song Yi ^a   Tharp, Anthony ^a   Ding, Lingmei ^a   Bannan, Jason D ^a   Mitchell, William M ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Multiple Sclerosis Res Laboratory   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN;

ADULT; ANTIBODY RESPONSE; ARTICLE; AUTOIMMUNITY; CEREBROSPINAL FLUID LEVEL; CHLAMYDOPHILA PNEUMONIAE; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOBLOTTING; INCIDENCE; ISOELECTRIC FOCUSING; MALE; MULTIPLE SCLEROSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REITER SYNDROME;

ADULT; BLOTTING, WESTERN; CHLAMYDIA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULINS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; POLYMERASE CHAIN REACTION;

EID: 0033011178     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/1531-8249(199907)46:1<6::AID-ANA4>3.0.CO;2-M     Document Type: Article

References (38)

1. Ward ME. The immunobiology and immunopathology of chlamydial infections. APMIS 1995;103:769-796
2. Peeling RW, Burnham RC. Chlamydiae as pathogens: new species and new issues. Emerging Inf Dis 1996;2:307-312
3. Stratton CW, Mitchell WM. The pathogenesis of Chlamydia species. Antimicrobics Infect Dis Newsl 1996;15:83-88
4. Beatty WL, Morrison RP, Byrne GI. Persistent chlamydiae, from cell culture to a paradigm for chlamydial pathogenesis. Microbiol Rev 1994;56:686-699
5. Storz J. Chlamydia and chlamydial induced diseases. Springfield, IL: Charles C Thomas, 1971:358
6. Wenner HA, Harshfield GS, Chang TW, Menges RW. Sporadic bovine encephalomyelitis. II. Studies on the etiology of the disease, isolation of nine strains of an infectious agent from naturally infected cattle. Am J Hyg 1953;57:15-22
7. Korman TM, Turnidge JD, Grayson ML. Neurologic complications of chlamydial infections: case report and review. Clin Infect Dis 1997;25:847-851
8. Saikku P. Chronic Chlamydia pneumoniae infections. In: Allegra L, Blasi F, eds. Chlamydia pneumoniae infection. Berlin: Springer-Verlag, 1995:51-64
9. Kuo C-C, Jackson LA, Campbell LA, Grayston JT. Chlamydia pneumoniae (TWAR). Clin Microbiol Rev 1995;8:451-461
10. Kuo C-C, Shor A, Campbell LA, et al. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J Infect Dis 1993;167:841-849
11. Braun J, Laitko S, Treharne J, et al. Chlamydia pneumoniae - a new causative agent of reactive arthritis and undifferentiated oligoarthritis. Ann Rheum Dis 1994;53:100-105
12. Gran JT, Hjetland R, Andreassen AH. Pneumonia, myocarditis and reactive arthritis due to Chlamydia pneumoniae. Scand J Rheumatol 1993;22:43-44
13. Saario R, Toivanen A. Chlamydia pneumoniae as a cause of reactive arthritis. Br J Rheumatol 1993;32:1112-1118
14. Moling O, Pegoretti S, Rielli M, et al. Chlamydiae pneumoniae-reactive arthritis. Br J Rheumatol 1996;35:1189-1190
15. Koskiniemi M, Gencay M, Salonen O, et al. C pneumoniae associated with CNS infections. Eur J Neurol 1996;36:160-163
16. Sriram S, Mitchell W, Stratton C. Multiple sclerosis associated with Chlamydia pneumoniae infection of the CNS. Neurology 1998;50:571-572
17. Maass M, Harig U. Evaluation of culture conditions used for isolation of Chlamydia pneumoniae. Am J Clin Pathol 1995; 103:141-148
18. Cles LD, Stamm WE. Use of HL cells for improved isolation and passage of Chlamydia pneumoniae. J Clin Microbiol 1990; 28:938-940
19. Kuo C-C, Grayston JT. A sensitive cell line, HL cells, for isolation and propagation of Chlamydia pneumoniae strain TWAR. J Infect Dis 1990;162:755-758
20. Theunissen JJH, van Heijst BYM, Wagenvoort JHT, et al. Factors influencing the infectivity of Chlamydia pneumoniae elementary bodies on HL cells. J Clin Microbiol 1992;30:1388-1391
21. Maass M, Harig U. Comparison of sample preparation methods for detection of Chlamydia pneumoniae in bronchoalveolar lavage fluid by PCR. Am J Clin Pathol 1995;103:141-148
22. Tjhie JHT, Roosendaal R, MacLaren DM, Vandenbroucke-Grauls CMJE. Improvement of growth of Chlamydia pneumoniae on HEp-2 cells by pretreatment with polyethylene glycol in combination with additional centrifugation and extension of culture time. J Clin Microbiol 1997;35:1883-1884
23. Kazuyama Y, Lee SM, Amamiya K. A novel method for isolation of Chlamydia pneumoniae by treatment with trypsin or EDTA. J Clin Microbiol 1997;35:1624-1626
24. Gaydos CA, Eiden JJ, Oldbach D, et al. Diagnosis of Chlamydia pneumoniae infection in patients with community-acquired pneumonia by polymerase chain reaction enzyme immunoassay. Clin Infect Dis 1994;19:157-160
25. Dalhoff K, Maass M. Chlamydia pneumoniae in hospitalized patients; clinical characteristic and diagnostic value of polymerase chain reaction detection in BAL. Chest 1996;110:351-356
26. Ladany S, Black CM, Farshy CE, et al. Enzyme immunoassay to determine exposure to Chlamydia pneumoniae (strain TWAR). J Clin Microbiol 1989;27:2778-2783
27. Friedank HM, Herr AS, Jacobs E. Identification of Chlamydia pneumoniae-specific protein antigens in immunoblots. Eur J Microbiol Infect Dis 1993;12:947-951
28. Campbell LA, Kuo C-C, Thissen RW, Grayston JT. Isolation of a gene encoding a Chlamydia sp strain TWAR protein that is recognized during infection of humans. Infect Immun 1989;57: 71-75
29. Haidl S, Ivarsson S, Bjerre I, Persson K. Guillain-Barre syndrome after Chlamydia pneumoniae infection. N Engl J Med 1992;326:576-577
30. Grayston JT, Kuo C-C, Coulson AS, et al. Chlamydia pneumoniae (TWAR) in atherosclerosis of the carotid artery. Circulation 1995;92:3397-3400
31. Wimmer MLJ, Sandmann-Strupp R, Saikku P, Haberl RL. Association of chlamydial infection with cerebrovascular disease. Stroke 1996;27:2207-2210
32. Wang LL, Henson E, McClarty G. Characterization of trimethoprim-and sulphisoxazole-resistant Chlamydia trachomatis. Mol Microbiol 1994;14:271-281
33. Hanna L, Merigan TC, Jawetz F. Inhibition of TRIC agents by virus induced interferon. Proc Soc Exp Med Biol 1966;122: 417-421
34. Kauppinen M, Saikku P. Pneumonia due to Chlamydia pneumoniae: prevalence, clinical features, diagnosis, and treatment. Clin Infect Dis 1995;21(Suppl 3):S244-S252
35. Gaydos CA, Summersgill JT, Sahney NN, et al. Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells. Infect Immun 1996;64:1614-1620
36. Yang Z-P, Kuo C-C, Grayston JT. Systemic dissemination of Chlamydia pneumoniae following intranasal inoculation in mice. J Infect Dis 1995;171:736-738
37. Moazed TC, Kuo C-C, Grayston JT, Campbell LA. Evidence of systemic dissemination of Chlamydia pneumoniae via macrophages in the mouse. J Infect Dis 1998;177:1322-1325
38. Sriram S. Future of MS therapeutics: rational approach targeting putative pathogenic mechanisms. In: Goodkind D, Rudick R, eds. MS: advances in trial design and therapeutics. New York: Springer, 1997:47-62